​Efficacy and safety of pyrotinib in combination with albumin‑bound paclitaxel for the treatment of HER2‑positive advanced breast cancer: A real‑world study

The present study aimed to determine the efficacy and safety of pyrotinib in combination with albumin-bound paclitaxel in patients with HER2-positive advanced breast cancer (ABC). A total of 48 patients diagnosed with HER2-positive ABC were included in the present study, and these patients were pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lixian, Zheng, Lei, Kong, Fanting, Tian, Xinli, Zhang, Shiyu, Pu, Pengpeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272970/
https://www.ncbi.nlm.nih.gov/pubmed/37332328
http://dx.doi.org/10.3892/ol.2023.13898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272970/
https://www.ncbi.nlm.nih.gov/pubmed/37332328
http://dx.doi.org/10.3892/ol.2023.13898

Ejemplares similares